Docoh
Loading...

FTRP Field Trip Health

News

Pro users get this 30m faster
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
13 Oct 21
Cannabis, Penny Stocks, Small Cap, Markets
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
This Psychedelic Therapies Stock Has A Better One-Year Return Than Nio, AMD, Nvidia And GE
13 Oct 21
News, Penny Stocks, Top Stories, Movers, Trading Ideas
Field Trip Health Ltd (NASDAQ: FTRP) is a global leader in psychedelic therapies, and over the past year, bringing eye-popping gains to investors’ portfolios.
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
4 Oct 21
Cannabis, Penny Stocks, Markets
The Week In Psychedelics:
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
1 Oct 21
Cannabis, Penny Stocks, Upgrades, Downgrades, Small Cap, Markets, Analyst Ratings, Trading Ideas
This article by Jason Najum was originally published on Microdose Psychedelic Insights and appears here with permission. The psychedelic medicine industry continues to get attention and gain credibility in the investment world.
Elon Musk Acknowledges Therapeutic Potential Of Psychedelic Drugs: Will This Impact The Markets?
29 Sep 21
Cannabis, Penny Stocks, Markets
Elon Musk expressed his support for the therapeutic potential of psychedelic drugs. The Space X and Tesla (NASDAQ: TSLA) CEO shared his opinion on psychedelic substances in a Q&A at the CodeCon event on Tuesday.
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
13 Sep 21
Cannabis, Penny Stocks, Markets
Last Week In Psychedelics:
Meet The Top 12 CEOs In The Psychedelics Industry
13 Sep 21
Biotech, Cannabis, News, Guidance, Exclusives, Markets, General
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate leaders, working to create new methods for the treatment of mental health and other serious conditions.
Psyched: Field Trip Gets $20 Price Target, DEA Seeks To Increase Psilocybin Production Limits, Synthesis Closes $7.25M Series A
7 Sep 21
Cannabis, Penny Stocks, Small Cap, Markets
Contents
Field Trip Stock Could Climb 300% In One Year
2 Sep 21
Cannabis, Price Target, Markets, Analyst Ratings
On Wednesday, HC WainWright began coverage of Field Trip Health (NASDAQ: FTRP), a company in the psychedelics space, which is developi
54 Biggest Movers From Yesterday
2 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday.
Why Field Trip Health Shares Are Trading Higher Today
1 Sep 21
News
Field Trip Health (NSADAQ: FTRP) shares are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and a $20 price target. The firm said it finds the company's valuation 'compelling' ahead of the anticipated Phase 1 top-line data on FT-104, saying it could be a 'disruptive psilocybin-like treatment.'
38 Stocks Moving In Wednesday's Mid-Day Session
1 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Focus Universal Inc. (NASDAQ: FCUV) shares jumped 108.2% to $10.62. The stock started trading on Nasdaq Capital Market yesterday.
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021
1 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
21 Stocks Moving in Wednesday's Pre-Market Session
1 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-19 diagnostic with Harvard's Wyss Institute.
HC Wainwright & Co. Initiates Coverage On Field Trip Health with Buy Rating, Announces Price Target of $20
1 Sep 21
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Field Trip Health (NASDAQ:FTRP) with a Buy rating and announces Price Target of $20.
75 Biggest Movers From Yesterday
4 Aug 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
2 Aug 21
Cannabis, Penny Stocks, Small Cap, Markets
Last week in Psychedelics:
Field Trip Health Debuts On Nasdaq With Average Performance, Looks To Expand Footprint Of Psychedelics Clinics
29 Jul 21
Cannabis, Markets
Field Trip Health (TSX: FTRP) (NASDAQ: FTRP) made its Nasdaq debut on Thursday, becoming the fifth company in the psychedelics space to receive a welcome by Wall Street this year.

Press releases

Pro users get this 30m faster
Field Trip Health Ltd. To Present At The KCSA Psychedelics Virtual Investor Conference On October 13th
12 Oct 21
Press Releases
TORONTO, Oct. 12, 2021 /PRNewswire/ -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today announced that Joseph del
Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028
11 Oct 21
Small Cap, Opinion, Press Releases
PALM BEACH, Fla., Oct. 11, 2021 /PRNewswire/ -- There is a high demand for more advanced products for the treatment and maintenance of severe mental disorders. Thus, pharmaceutical companies are investing a huge amount
Field Trip Health Announces Voting Results From the Annual General and Special Meeting of Shareholders
24 Sep 21
News, Management, Press Releases
TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), today announced the voting results from its Annual General and Special Meeting of Shareholders
Field Trip Health Ltd. to Participate in Four Investor Conferences in September
10 Sep 21
News, Press Releases
TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, today announced it will
Field Trip Health Ltd. Announces Launch Of "Kap Co-Operative" Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians
31 Aug 21
Press Releases, General
The KAP Co-op program gives eligible therapists the ability to provide ketamine-assisted psychotherapy (KAP) to their patients at Field Trip Health Centers utilizing Field Trip's medical teams for screening, prescribing
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
16 Aug 21
Earnings, Press Releases
At June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investmentsDevelopment of FT-104, a novel psychedelic molecule with pending patents, continues
Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET
10 Aug 21
News, Press Releases
TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, FTRP.WT, NASDAQ:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that